News & Updates
Filter by Specialty:
Does multiple biosimilar switching induce flare in IBD patients?
17 Feb 2024
byStephen Padilla
Multiple biosimilar infliximab (IFX) switching among patients with inflammatory bowel disease (IBD) does not seem to give rise to disease flares at 12 months compared to those who continued using IFX originator or those on single IFX biosimilar switch, a study has shown.